DPB1 T-Cell Epitope Algorithm v2.1

Classification of HLA-DPB1 mismatches based on T-cell-epitope groups (TCE-groups) has been shown to identify mismatches that might be better tolerated (permissive) and those that would increase risks (non-permissive) after unrelated-donor haematopoietic stem cell transplantation (HSCT). This calculator allows you to enter the HLA-DPB1 typing of a patient and a donor and retrieve the predicted TCE grouping and resulting matching/mismatching when selecting appropriate donors for HSCT recipients.

Advice on the user of this tool:

  • Please provide HLA-DPB1 typing at 2 field resolution, or higher. P groups are also accepted.
  • All HLA-DPB1 typing provided should be at the same resolution level (2 field, 3 field, 4 field or P group)
  • TCE group assignments between version 2.0 and 2.1 have not changed, however developments in our understanding of immunopeptidome divergence (see Meurer et al. Blood 2021) and the inclusion of bi-directional immunogenicity (see Fleischhauer et al/ BMT 2017) in the algorithm have led to changes in the permissiveness of some mismatch constellations. Version 2.1 and 3 of this tool reflect the current state of the art in terms of TCE assignments and matching.
  • For example:
    • Patient DPB1*03:01 (TCE 2), DPB1*04:01 (TCE 3) and Donor DPB1*03:01 (TCE 2), DPB1*03:01 (TCE 2)
    • In version 2.0 this mismatch would have been predicted as "Permissive", however in version 2.1 this is now predicted as "Non permissive GvH"
  • This tool has been developed in collaboration with the original authors and validated with their support.
  • No information entered into this tool is collected or stored on our servers.
Patient and Donor Typing:
Add Further Donors
Do Not Add Further Donors
Clear

Disclaimer - This tool is being offered as a tool to predict T-Cell epitope matching at DPB1 as reported in:

References

No information entered into this tool is collected or stored on our servers.

API

An API has been developed for this tool, please see our API Documentation for further details